Morningstar Investment Management LLC Invests $665,000 in HCA Healthcare, Inc. $HCA

Morningstar Investment Management LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,735 shares of the company’s stock, valued at approximately $665,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth $1,021,000. Farther Finance Advisors LLC grew its stake in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after acquiring an additional 242 shares during the period. GAMMA Investing LLC boosted its stake in HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after purchasing an additional 737 shares during the period. Stock Yards Bank & Trust Co. bought a new position in HCA Healthcare in the 1st quarter worth about $394,000. Finally, Ritholtz Wealth Management boosted its stake in HCA Healthcare by 19.4% in the 1st quarter. Ritholtz Wealth Management now owns 8,992 shares of the company’s stock worth $3,107,000 after purchasing an additional 1,462 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.1%

Shares of NYSE HCA opened at $410.71 on Tuesday. The stock has a market cap of $96.10 billion, a price-to-earnings ratio of 17.26, a P/E/G ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $439.01. The stock’s 50-day moving average is $406.07 and its 200 day moving average is $376.56.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analyst Weigh In

Several research analysts have commented on HCA shares. Cantor Fitzgerald restated an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 7th. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. The Goldman Sachs Group set a $470.00 target price on HCA Healthcare in a research note on Tuesday. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Finally, UBS Group set a $465.00 price target on HCA Healthcare in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $425.71.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.